All News

Reading, writing, art, music... CURE recently asked its social media audience to share the creative outlets and activities that have helped them on their cancer journey. Here are some of their responses – in the hopes of helping others find a new hobby of their own.

Like many people who receive a cancer diagnosis, one survivor questions the reason.

From Matthew Knowles revealing a male breast cancer and BRCA2 diagnosis to a sarcoma survivor donating thousands of toys in lieu of birthday presents, here’s what is making headlines in the cancer space this week.

Knowing your family history is the first preventative step any woman can take to avoid a diagnosis of ovarian cancer.

Phase 3 trial findings showed that treatment with Lynparza delayed disease progression by about four months compared with newer hormonal agents in pre-treated patients with metastatic castration-resistant prostate cancer and faulty DNA repair genes.

Every cancer survivor has days when negative thoughts take over. Why not use visualization of video games to get rid of the self-defeating ideas?

Here’s a look at what’s inside our 2019 Immunotherapy special issue.

Searching for healthcare information online is a fact of life. Here are some ideas for how to do it responsibly.

"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."

CURE spoke with an expert on how patients can better advocate for themselves when it comes to genetic testing and its follow-up.

Let music keep you company during and after cancer.

Here are the top five CURE stories for September 2019.

Readers of CURE share the ways that cancer has changed their lives.

A male breast cancer survivor discovers that looking ahead may be good for our health.

Ovarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.

The Food and Drug Administration expanded its approval of Cologuard, an at-home non-invasive colorectal cancer screening test, to include use among average-risk individuals aged 45 and older.

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

A two-time cancer survivor discusses her recently-discovered pancreatic cysts.

From a freezer failure that lost the stem cells of some patients with cancer to a documentary about one of the pioneers of immunotherapy, here’s what is making headlines in the cancer space this week.

The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.

Influenza season is almost here. In an effort to prevent the spread of the viral infection, some doctors recommend an annual vaccine. In this post, one survivor shares what happened when she shared details about her breast cancer and lymphedema experience before receiving the vaccine.

In this episode of the “Cure Talks Cancer” podcast, we spoke with Joan DelFattore about how she overcame the physician bias she encountered during her cancer treatment.

Here’s a look at what’s inside our 2019 Hematology special issue.

A survivor reflects on having her breast implants removed as she hopes to turn the page in her cancer journey.

Here is a list of the recent trial initiations that occurred within the cancer space in September.

A recent survey found that lung cancer stigma can be a barrier to treatment; however, on the plus side, the percentage of people who associate the disease with smoking has dropped in recent years.

October is upon us. That means much of our world can turn pink. Pink shirts, shoes, bags, jewelry, hair... I could go on. Many people buy items to support breast cancer education and research. Educating yourself as to where your money goes can be important.

CURE spoke with an expert from Mount Sinai to discuss the future of ovarian cancer treatment and his advice for women facing a new diagnosis.

A subgroup of women with advanced endometrial cancer now have a second-line treatment option to turn to after progressing on chemotherapy.

Just when a patient with cancer is ready to throw in the towel is often when the tide turns.